Recruiting Spinal Muscular Atrophy Studies in New York
About Spinal Muscular Atrophy Clinical Trials in New York
Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.
There are currently 59 spinal muscular atrophy clinical trials recruiting participants in New York, NY. These studies are seeking a combined 11,247 participants. Research is being sponsored by BioNTech SE, Revolution Medicines, Inc., Eikon Therapeutics and 30 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Spinal Muscular Atrophy Clinical Trials in New York — FAQ
Are there spinal muscular atrophy clinical trials in New York?
Yes, there are 59 spinal muscular atrophy clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What spinal muscular atrophy treatments are being tested?
The 59 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.
Data updated September 1, 2026 from ClinicalTrials.gov